On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
ThursdayDec 08, 2022 1:50 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Latest DehydraTECH-CBD Study May Be 1st to Evidence Sustained Drop in Blood Pressure

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs, has, since inception, been committed to addressing severe unmet patient needs. Hypertension has been one of its main focus areas. “Lexaria continues to move forward, most recently with the success in its latest human clinical study, HYPER-H21-4. The study may be the first to evidence a sustained drop in blood pressure in normally active patients following multiple weeks of oral cannabidiol (‘CBD’) therapy using the company’s patented DehydraTECH(TM) technology,” reads a recent article. “Since Lexaria began developing DehydraTECH…

Continue Reading

ThursdayDec 08, 2022 12:44 pm

CannabisNewsBreaks – REZYFi Inc. Leveraging Corporate Strengths to Capitalize on Growth in Multiple Verticals

REZYFi is positioned as the first cannabis mortgage banker in the United States. With most traditional lenders reticent to serve the state-licensed cannabis industry, REZYFi stands distinct. “REZYFi services the needs of both traditional and non-traditional consumers and businesses. The company is targeting markets that include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financings, such as solar installations and real estate development projects,” a recent article reads. “REZYFi operates under two wholly owned subsidiaries –…

Continue Reading

WednesdayDec 07, 2022 12:54 pm

CannabisNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Return Local Control, Improve Food Quality

Advanced Container Technologies (OTC: ACTX) offers unique controlled environment farms called GrowPods, which can help reduce the environmental impact of traditional farming and enable year-round cultivation of nutritious food. According to a report republished in Science Direct, “hydroponic closed-environment agriculture could play a role in positive food system transformation, reducing environmental footprints, sparing land, and potentially helping to reconnect consumers with producers.” Further, according to Forbes, large volumes of greens are being grown indoors, even from retail giants, and controlled environmental agriculture is catching on and increasing in popularity. Doug Heldoorn, CEO of ACTX, said GrowPods are transportable and scalable,…

Continue Reading

WednesdayDec 07, 2022 12:01 pm

CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Applauds Milestone Development for Medical Cannabis Industry

India Globalization Capital (NYSE American: IGC) applauds the signing of the Medical Marijuana and Cannabidiol Research Expansion Act, which was signed into law by President Biden on Friday Dec. 2, 2022. The legislation establishes a new registration process for conducting research on marijuana and for manufacturing marijuana products for research purposes and drug development. “The study and development of cannabis for its potential therapeutic benefits is at the center of our work at IGC-Pharma,” said Ram Mukunda, CEO of IGC. “For many years, onerous federal barriers have made it difficult to efficiently source and study cannabis for pharmaceutical applications. We…

Continue Reading

FridayDec 02, 2022 3:50 pm

CannabisNewsBreaks – REZYFi Inc. Capitalizing on Expected Demand for Innovative Financing Offerings by Players in Cannabis Market

REZYFi and its wholly owned subsidiaries, REZYFi Lending and ResMac, have sought to fill a gap that currently sees cannabis-related companies struggle to obtain financing from traditional banks. Traditional banks abide by federal law, which criminalizes marijuana use. “In fact, REZYFi believes cannabis-related firms will continue to experience difficulties obtaining financing from traditional sources – rescheduling efforts notwithstanding – creating opportunity for the company. REZYFi is a growth mortgage origination and specialized financing company headquartered in Miami, Florida. The company primarily offers a variety of real-estate-related first and additional mortgage-based financing and project-specific financings to licensed and permitted cannabis companies…

Continue Reading

FridayDec 02, 2022 10:50 am

CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Commences Trial Evaluating IGC-AD1 for the Treatment of Alzheimer’s-Related Symptoms

India Globalization Capital (NYSE American: IGC) announced that it has begun “A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants with Dementia due to Alzheimer’s Disease.” According to the announcement, the company has commenced the phase 2 study at two U.S. sites and plans to add between three to five additional sites in the United States, Canada and possibly South America. “We believe that IGC-AD1 has the potential to revolutionize the treatment of Alzheimer’s Disease as the first and only low-dose natural THC-based formulation candidate currently undergoing FDA trials,” said…

Continue Reading

ThursdayDec 01, 2022 10:58 am

CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) to Present at RHK 2022 Disruptive Growth Conference

India Globalization Capital (NYSE American: IGC) has announced that its Chief Executive Officer Ram Mukunda will be presenting at the RHK Disruptive Growth Conference in New York City. Mukunda is slated to present beginning at 11:20 a.m. ET on Monday, Dec. 5, and will also be available for one-on-one meetings on Monday, Dec. 5 and Tuesday, Dec. 6. To view the full press release, visit https://cnw.fm/MZzYM About India Globalization Capital Inc. India Globalization Capital develops advanced cannabinoid-based formulations for treating diseases, including but not limited to Alzheimer’s, Parkinson’s, chronic pain, and pet seizures. The company’s leading drug candidate, IGC-AD1, has…

Continue Reading

WednesdayNov 30, 2022 3:21 pm

CannabisNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Can Help Feed the Hungry Throughout America

Advanced Container Technologies (OTC: ACTX) offers unique controlled environment farms called GrowPods, which can help non-profit agencies, schools and community groups reduce food insecurity. According to the USDA, more than 34 million people in the United States, including 9 million children, are food insecure. This means that one in eight U.S. kids are living with hunger. Thanks to advances in technology, non-profit organizations, schools, places of worship, and civic groups can now grow food in an automated, controlled system, right within the communities they serve. However, while farming is generally not commonplace among food banks, controlled environment farms like GrowPods…

Continue Reading

TuesdayNov 29, 2022 2:01 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD(TM) Demonstrates Enhanced Performance Compared to Leading Anti-Seizure Medication

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its patented DehydraTECH-CBD(TM) has demonstrated performance enhancements compared to one of the world’s leading anti-seizure medications, Epidiolex(R). According to the update, animal study program EPIL-A21-1 was designed to determine whether DehydraTECH-CBD could provide similar seizure inhibiting efficacy, using an established, vehicle-controlled, acute animal seizure model induced by electrical stimulation (“MES”), at lower doses than were required with Epidiolex, the world’s only commercially approved, CBD-powered anti-seizure drug. In order to minimize adverse side effects, Lexaria is continually searching for the lowest possible efficacious dose levels of…

Continue Reading

MondayNov 28, 2022 11:12 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Q3 2022 Financial Results

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, released its financial and operating results for the third quarter and nine months ended Sept. 30, 2022. Among the highlights, the company reported 414% year-over-year and 510% year-over-year increases in revenue for the three-month period and nine-month period ended Sept. 30, 2022. In addition, Flora achieved a 703% year-over-year increase in gross profit for the three-month period ended Sept. 30, 2022. The company will discuss these results in its earnings call at 4:30 p.m. ET today, as detailed in the press release. “The third…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722